Clinical Trial Update: A Sleep Laboratory Study to Investigate the Safety and Efficacy of the Rotigotine Skin Patch in Subjects With Restless Legs Syndrome and End-Stage Renal Disease Requiring Hemodialysis [Phase 3]

View source ↗

Summary

Phase 3 trial assessing the safety and efficacy of a rotigotine transdermal patch for restless legs syndrome in patients with end-stage renal disease on hemodia…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease
• Restless Legs Syndrome

Drugs mentioned

• Neupro (rotigotine)

Snippet

Sponsor: UCB BIOSCIENCES GmbH | Conditions: Restless Legs Syndrome, End-Stage Renal Disease | Phase 3 | Status: COMPLETED | Results posted: 2014-11-03